BSFA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ANI Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 54.5 EUR

Market Cap: €1.1B

A	ANI Pharmaceuticals Inc F:BSFA	US
	Energy of Minas Gerais Co F:CIDS	BR
	Loomis AB F:K900	SE
	ExpreS2ion Biotech Holding AB STO:EXPRS2	SE
	NVIDIA Corp NASDAQ:NVDA	US
	Cidara Therapeutics Inc F:20D0	US
H	Helmerich and Payne Inc XMUN:HPC	US
	AxoGen Inc F:LT3	US
S	Siemens AG XMUN:SIE	DE

Profitability Summary

ANI Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

60%

Strong 3Y Average Gross Margin

61%

Declining Gross Margin

63% > 60%

Healthy Operating Margin

15%

Low 3Y Average Operating Margin

Operating Margin is Increasing

10% > 15%

Healthy Net Margin

10%

Low 3Y Average Net Margin

Net Margin is Increasing

2% > 10%

Exceptional Free Cash Flow Margin

18%

Strong 3Y Average Free Cash Flow Margin

16%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.